We are live on ! Find out more
BC

Bruce & Co Portfolio holdings

AUM $350M
1-Year Est. Return 33.5%
This Fund
S&P 500
This Quarter Est. Return
-0.58%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$471M
AUM Growth
-$52.9M
Cap. Flow
-$67.8M
Cap. Flow %
-14.41%
Top 10 Hldgs %
72.37%
Holding
33
New
3
Increased
1
Reduced
19
Closed
2

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$9.46M
2
UHAL icon
U-Haul Holding Co
UHAL
+$8.53M
3
ABBV icon
AbbVie
ABBV
+$7.38M
4
CHMA
Chiasma, Inc. Common Stock
CHMA
+$5.91M
5
AAPL icon
Apple
AAPL
+$5.53M

Sector Composition

Rank Sector Weight
1 Healthcare 37.46%
2 Utilities 27.42%
3 Industrials 13.24%
4 Financials 8.16%
5 Technology 7.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UHAL icon
1
U-Haul Holding Co
UHAL
$13.9B
$51.5M 10.95%
797,850
-136,000
-15% -$8.53M
NEE icon
2
NextEra Energy
NEE
$185B
$39.4M 8.36%
501,400
-41,600
-8% -$3.36M
BHC icon
3
Bausch Health
BHC
$1.8B
$38.5M 8.17%
1,381,000
-45,000
-3% -$1.28M
ALL icon
4
Allstate
ALL
$64.3B
$38.2M 8.11%
299,800
-24,000
-7% -$3.17M
AAPL icon
5
Apple
AAPL
$4.9T
$34.3M 7.3%
242,700
-37,550
-13% -$5.53M
ABBV icon
6
AbbVie
ABBV
$450B
$32.7M 6.96%
303,500
-64,626
-18% -$7.38M
CMS icon
7
CMS Energy
CMS
$22.8B
$28M 5.95%
468,500
-23,300
-5% -$1.45M
DUK icon
8
Duke Energy
DUK
$97.5B
$27.9M 5.93%
286,200
-11,300
-4% -$1.17M
XEL icon
9
Xcel Energy
XEL
$49.2B
$25.8M 5.48%
412,500
-22,600
-5% -$1.53M
MRK icon
10
Merck
MRK
$315B
$24.3M 5.17%
323,700
-6,500
-2% -$494K
PFE icon
11
Pfizer
PFE
$143B
$23.4M 4.98%
544,700
-21,932
-4% -$972K
ABT icon
12
Abbott
ABT
$175B
$21M 4.46%
177,600
-77,000
-30% -$9.46M
GE icon
13
GE Aerospace
GE
$364B
$10.8M 2.28%
167,532
-3,009
-2% -$193K
SUPN icon
14
Supernus Pharmaceuticals
SUPN
$2.79B
$10.7M 2.28%
402,105
AVA icon
15
Avista
AVA
$3.45B
$8.02M 1.7%
205,000
-3,500
-2% -$147K
PRTK
16
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$6.53M 1.39%
1,343,312
+180,000
+15% +$992K
SIRI icon
17
SiriusXM
SIRI
$10.3B
$5.23M 1.11%
85,784
-30,000
-26% -$1.89M
AMYT
18
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$4.92M 1.05%
+407,440
New +$4.6M
IGMS
19
DELISTED
IGM Biosciences
IGMS
$3.62M 0.77%
55,000
FOCL
20
EDAP TMS S.A.
FOCL
$204M
$3.61M 0.77%
565,652
-45,726
-7% -$280K
NEM icon
21
Newmont
NEM
$95.8B
$3.53M 0.75%
65,000
FATE icon
22
Fate Therapeutics
FATE
$324M
$3.38M 0.72%
57,000
-5,000
-8% -$392K
MNKD icon
23
MannKind Corp
MNKD
$1.25B
$1.72M 0.37%
395,073
ASH icon
24
Ashland
ASH
$3.14B
$1.23M 0.26%
25,000
OGN icon
25
Organon & Co
OGN
$3.55B
$1.06M 0.23%
+32,370
New +$1.04M

Similar funds

Bruce & Co's Q3 2021 Portfolio in Review

As of Q3 2021, Bruce & Co held 33 positions worth $471M, down 10% from $524M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Bruce & Co withdrew a net $67.8M in Q3 2021, closing 2 positions and reducing 19 holdings. Its most notable exit was Chiasma, Inc. Common Stock, an estimated $5.91M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 39% a quarter earlier, followed by Utilities and Industrials.

Against the trend, Bruce & Co opened a new position in Amryt Pharma plc American Depositary Shares worth $4.92M.

  • Bruce & Co's largest Q3 2021 buy was Amryt Pharma plc American Depositary Shares: 407,440 shares worth $4.92M.
  • Bruce & Co added most to Paratek Pharmaceuticals, Inc. in Q3 2021, an estimated $992K increase.
  • Bruce & Co's biggest Q3 2021 reduction was Abbott, cutting an estimated $9.46M.
  • Bruce & Co fully exited Chiasma, Inc. Common Stock in Q3 2021, selling an estimated $5.91M.
  • Bruce & Co's ten largest holdings make up 72% of its $471M portfolio in Q3 2021.
  • Bruce & Co opened 3 new positions and closed 2 in Q3 2021.
  • Bruce & Co's portfolio value fell 10% quarter-over-quarter to $471M.

Based on Bruce & Co's 13F filing for Q3 2021, filed 12 Nov 2021.